Search for: "TEVA PHARMACEUTICAL INDUSTRIES LTD"
Results 181 - 200
of 257
Sort by Relevance
|
Sort by Date
20 Aug 2009, 1:06 pm
District Court Judge Garrett Brown rejected the argument made by Teva Pharmaceuticals Industries Ltd. that the patent covering the main ingredient in Merck & Co. [read post]
7 Aug 2009, 1:54 pm
On Wednesday, Teva Pharmaceutical Industries Ltd. sued Merrill Lynch & Co., a Bank of America Corp. unit. [read post]
24 Jul 2009, 1:31 am
District Court for the District of New Jersey overseeing the case upholds the validity and enforceability of J&J's patent.Teva had issued a press release on 1 July 09:Teva Pharmaceutical Industries Ltd. [read post]
1 Jul 2009, 7:14 am
(Patent Docs) Products Avapro (Irbesartan) – Spain: Fourth Commercial Court of Barcelona rejects preliminary injunction petition by Sanofi-Aventis and Bristol-Myers Squibb for alleged patent infringement (International Law Office) Cozaar/Hyzaar (Losartan/Hydrochlorothiazide and Losartan) –US: Teva sues FDA over generic Cozaar and Hyzaar 180-day exclusivity forfeiture and patent delisting rule (The FDA Law Blog) Eloxatin (Oxaliplatin) – US: District Court of… [read post]
30 Jun 2009, 7:03 pm
Teva Pharmaceuticals USA, a wholly-owned subsidiary of Teva Pharmaceutical Industries Ltd., is making a full-court press on getting the word out on the need for follow-on biologics. [read post]
28 Jun 2009, 3:08 pm
• Defendants: Teva Parenteral Medicines, Inc.; Teva Pharmaceuticals USA, Inc.; Teva Pharmaceutical Industries Ltd. [read post]
27 May 2009, 9:55 pm
Teva Pharmaceutical Industries Ltd. et al. v. [read post]
9 Apr 2009, 7:52 am
(IP Think Tank) Brazilian public-private partnerships in the pharma industry (IP tango) EU: ECJ to rule on reference on SPC Regulation interpretation from Lithuania in Kirin Amgen, Inc. v Lietuvos Respublikos valstybinis patentų biuras (The SPC Blog) India: Delhi High Court Dasatinib order: Is patent-drug regulatory linkage a necessity? [read post]
24 Mar 2009, 8:59 pm
By Suresh Pillai -- Settlement Announced in SOLODYN ® Patent Dispute Last week, Teva Pharmaceutical Industries Ltd. and Medicis Pharmaceutical Corp. entered into a settlement agreement that effectively ends a dispute between the two companies over the patent family covering SOLODYN ® (minocycline HCL, used to treat acne) Extended Release Tablets. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
23 Jan 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: India: Discussion of Delhi High Court Dasatinib order – patent linkage between Indian Patent Office and Office of the Drug Controller General of India (Patent Circle) (Spicy IP) (Patent Circle) (Managing Intellectual Property) Lescol (Fluvastatin) – US: EWHC finds sustained release Fluvastatin patent invalid on ground of… [read post]
19 Jan 2009, 2:56 pm
Boston, Massachusetts– According to a January 5, 2009 report by Dow Jones Newswires, Teva Pharmaceutical Industries Ltd. [read post]
11 Dec 2008, 10:30 pm
In response, the plaintiffs, Eli Lilly and Company and Lilly Industries Ltd. [read post]
28 Nov 2008, 12:49 pm
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: EPO Enlarged Board of Appeal turns down Wisconsin Alumni Research Foundation (WARF) stem cell application (IAM) (IPKat) (EPO) European Commission releases… [read post]
8 Nov 2008, 2:24 pm
Japanese drug major, Takeda Pharmaceuticals Co. has won a US appeals court ruling that delays Teva Pharmaceutical Industries Ltd. from selling a generic version of the heartburn drug Prevacid, generically Lansoprazole until next year. [read post]
20 Oct 2008, 3:34 am
Teva Pharmaceutical Industries Ltd et al.1:08-cv-01071; filed October 14, 2008 in the Eastern District of VirginiaDeclaratory judgment of non-infringement, invalidity, and unenforceability of U.S. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US:… [read post]
10 Oct 2008, 11:32 am
:Interpharma Pty Ltd v Commisioner of Patents (GenericsWeb) Gemzar (Gemcitabine) - US: Eli Lilly sues Teva for patent infringement and seek declaratory judgment (The IP Factor) (Law360) Glivec (Imatinib) - India: Supreme Court appoints Dr Chakraborty as technical member on IPAB panel hearing Glivec appeal (Spicy IP) Jeevani (Arogyapacha) - India: Recent developments in the Arogypacha case (Spicy IP) Miralax (Polyethylene glycol) - US: 'Advice of scientist'… [read post]
25 Sep 2008, 4:23 am
By Donald Zuhn -- Last week, Teva Pharmaceutical Industries Ltd. announced that the European Commission's Directorate General for Enterprise and Industry has granted the company a marketing authorization for its human granulocyte colony stimulating factor (G-CSF) product. [read post]
23 Sep 2008, 9:34 pm
FDA To Collaborate With Complaining Patients On Study Of Reported Problems With This Generic Version Of Antidepressant Wellbutrin XL (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a September 23, 2008 Wall Street Journal (WSJ) article, "Wellbutrin Generic to Get New Review", we learned that the FDA is going to re-visit the issues of whether Budeprion XL -- which is made by Impax Laboratories Inc. and distributed by Teva Pharmaceutical Industries… [read post]
